Gastric Cancer Management and Outcomes
Gastric Cancer Management and Outcomes is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 64k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers represents a comprehensive exploration of gastric cancer, covering topics such as chemotherapy, endoscopic resection, molecular characterization, lymph node dissection, adjuvant and neoadjuvant therapy, clinical practice guidelines, metastatic gastric cancer, and survival analysis.
- Gastric Cancer
- Chemotherapy
- Endoscopic Resection
- Molecular Characterization
- Lymph Node Dissection
- Adjuvant Therapy
- Clinical Practice Guidelines
- Neoadjuvant Chemotherapy
- Metastatic Gastric Cancer
- Survival Analysis
- Research works
- 64k fractional, since 1950
- In the world top 10%
- 6.5k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +5% the tick is no change
- Largest producer
China
33% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Gastric Cancer Management and Outcomes research?
By volume, China and the United States publish the most (3.5k and 2.2k works in 2022-now).
By volume, 2022-now
- 1
China 3.5k works
- 2
United States 2.2k works
- 3
Japan 1.8k works
- 4
South Korea 657 works
- 5
United Kingdom 581 works
- 6
Italy 482 works
- 7
Germany 410 works
- 8
India 398 works
- 9
Spain 302 works
- 10
Russia 268 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Gastric Cancer Management and Outcomes research?
By volume in 2022-now, Sun Yat-sen University publishes the most Gastric Cancer Management and Outcomes research, followed by Fujian Medical University and Nanjing Medical University.
By volume, 2022-now
- 1
Sun Yat-sen University
China 145 works
- 2
Fujian Medical University
China 111 works
- 3
Nanjing Medical University
China 105 works
- 4
Chinese Academy of Medical Sciences & Peking Union Medical College
China 95 works
- 5
Sichuan University
China 95 works
- 6
Peking University
China 92 works
- 7
Shanghai Jiao Tong University
China 82 works
- 8
Harvard University
United States 81 works
- 9
Mayo Clinic
United States 76 works
- 10
Zhejiang University
China 74 works
Who are the leading researchers in Gastric Cancer Management and Outcomes?
The most-cited researchers publishing on Gastric Cancer Management and Outcomes include Ahmedin Jemal, Rebecca L. Siegel and Freddie Bray.
- 1
Ahmedin Jemal
United States 761k citations
- 2
Rebecca L. Siegel
United States 582k citations
- 3
Freddie Bray
France 550k citations
- 4
Zhong Lin Wang
United States 491k citations
- 5
Jacques Ferlay
France 486k citations
- 6
Ali H. Mokdad
United States 429k citations
- 7
Walter Churchill Willett
United States 411k citations
- 8
Bert Vogelstein
United States 373k citations
- 9
Gad A. Getz
United States 364k citations
- 10
Hermann Brenner
Germany 343k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Gastric Cancer Management and Outcomes research done?
The largest centres of Gastric Cancer Management and Outcomes research in 2022-now are Tokyo (Japan), Beijing (China), Seoul (South Korea) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Kashiwa and Plainview.
Largest cities, 2022-now
Where it is the local speciality
- KashiwaJP · 65.6 works54×
- PlainviewUS · 35.6 works33×
Location quotient: how much more of its research is in Gastric Cancer Management and Outcomes than the world average.
Where is the best place to study Gastric Cancer Management and Outcomes?
Among universities, judged by research, Sun Yat-sen University, Fujian Medical University and Utrecht University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Gastric Cancer Management and Outcomes, country by countryIs Gastric Cancer Management and Outcomes research growing?
Output in 2022-2025 was 5% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Gastric Cancer Management and Outcomes.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Gastric Cancer Management and Outcomes as a percentage of every work published that year, 0.061% in 2024.
Fractional works of Gastric Cancer Management and Outcomes over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Gastric Cancer Management and Outcomes. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.